CINECA IRIS Institutional Research Information System

DANIELE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.571
AS - Asia 3.198
EU - Europa 2.897
SA - Sud America 616
AF - Africa 167
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.459
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.335
IT - Italia 1.457
SG - Singapore 977
CN - Cina 816
HK - Hong Kong 665
BR - Brasile 521
SE - Svezia 340
VN - Vietnam 291
CA - Canada 202
DE - Germania 189
GB - Regno Unito 179
BG - Bulgaria 171
FR - Francia 123
AT - Austria 88
IN - India 79
RU - Federazione Russa 79
FI - Finlandia 76
CI - Costa d'Avorio 64
JP - Giappone 55
TR - Turchia 51
AR - Argentina 39
IQ - Iraq 33
NL - Olanda 33
KR - Corea 32
BD - Bangladesh 30
PL - Polonia 27
SN - Senegal 24
ID - Indonesia 23
IE - Irlanda 22
ES - Italia 21
ZA - Sudafrica 21
MX - Messico 20
CH - Svizzera 18
BE - Belgio 17
PK - Pakistan 17
MA - Marocco 15
MY - Malesia 15
SA - Arabia Saudita 13
UA - Ucraina 13
EC - Ecuador 12
UZ - Uzbekistan 12
NG - Nigeria 11
LT - Lituania 10
VE - Venezuela 10
CO - Colombia 9
KZ - Kazakistan 9
EG - Egitto 8
LB - Libano 8
PT - Portogallo 8
TW - Taiwan 8
AU - Australia 7
CZ - Repubblica Ceca 7
IL - Israele 7
IR - Iran 7
JO - Giordania 7
PE - Perù 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
OM - Oman 6
UY - Uruguay 6
AZ - Azerbaigian 5
PH - Filippine 5
PY - Paraguay 5
BO - Bolivia 4
ET - Etiopia 4
KE - Kenya 4
BJ - Benin 3
BY - Bielorussia 3
GE - Georgia 3
JM - Giamaica 3
MN - Mongolia 3
NP - Nepal 3
PS - Palestinian Territory 3
RO - Romania 3
CL - Cile 2
DZ - Algeria 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
MU - Mauritius 2
NO - Norvegia 2
PA - Panama 2
TT - Trinidad e Tobago 2
AL - Albania 1
BB - Barbados 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HN - Honduras 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
KY - Cayman, isole 1
MD - Moldavia 1
ME - Montenegro 1
MZ - Mozambico 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
Totale 13.450
Salva come PNG Salva come JPEG
Città #
Hong Kong 657
Dallas 645
Ashburn 612
Woodbridge 538
Singapore 527
San Jose 499
Fairfield 489
Ann Arbor 431
Houston 365
Santa Clara 353
Chandler 251
Serra 248
Beijing 215
Seattle 212
Milan 185
Cambridge 172
Shanghai 172
Sofia 165
Ottawa 158
Wilmington 153
New York 146
Los Angeles 104
Pisa 103
Boardman 102
Rome 100
Florence 84
Ho Chi Minh City 80
Princeton 79
Lawrence 68
Abidjan 64
Vienna 63
Hefei 59
Lauterbourg 59
London 54
Medford 53
Frankfurt am Main 48
Hanoi 47
Munich 47
São Paulo 46
Tokyo 45
Council Bluffs 41
Des Moines 40
Lancaster 39
Redondo Beach 34
Redwood City 34
Dong Ket 31
Chicago 29
Naples 28
Buffalo 27
Seoul 26
Dearborn 25
Istanbul 25
Dakar 24
Helsinki 24
San Diego 24
Nanjing 23
Warsaw 22
Boulder 21
Bremen 21
Cascina 20
Rio de Janeiro 20
Turku 19
Marseille 18
Brussels 17
Mendicino 17
Paris 17
Fuzhou 16
San Francisco 16
Lucca 15
Nuremberg 15
Ogden 15
Orem 15
Verona 14
Baltimore 13
Belo Horizonte 13
Brasília 13
Da Nang 13
Sligo 13
Chennai 12
Guangzhou 12
Brooklyn 11
Johannesburg 11
Kuala Lumpur 11
Lagos 11
Livorno 11
Tianjin 11
Turin 11
Atlanta 10
Orta di Atella 10
Tashkent 10
Catania 9
Denver 9
Baghdad 8
Bern 8
Cava Dei Tirreni 8
Changsha 8
Montreal 8
Shenyang 8
Zurich 8
Almaty 7
Totale 9.547
Salva come PNG Salva come JPEG
Nome #
UN INSOLITO CASO DI IPOGLICEMIA IPERINSULINEMICA DA NESIDIOBLASTOSI E INSULINOMA 785
Altered Visual Plasticity in Morbidly Obese Subjects 271
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection 246
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus 245
Brain effect of bariatric surgery in people with obesity 218
Effects of bariatric surgery on brain glucose metabolism and cognitive function: insight from dynamic FDG PET/CT study 214
Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. 207
Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 207
Exenatide modulates visual cortex responses 203
Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality 202
The effects of bariatric surgery on the brain glucose metabolism and its biological mediators: an insight from dynamic 18F-FDG PET/CT study 200
Optimizing management of metabolic syndrome to reduce the risk: focus on life-style 197
Effects of Intermittent Fasting on Brain Metabolism 194
Circulating Endothelial Cells (EPC) and Endothelium-derived Microparticles (EdMPs) time-course throughout the natural history of type 2 diabetes 194
Serum gamma-glutamyltransferase levels are related to insulin sensitivity and secretion in subjects with abnormal glucose regulation 188
Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious? Reply to Rigalleau V, Blanco L, Alexandre L et al [letter] 186
Insulin secretion and action affect glucose variability in the early stages of glucose intolerance 181
Impaired brain plasticity in obesity: effects of bariatric surgery and gut hormones 181
Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus 180
Dapagliflozin lowers plasma glucose concentration and improves β-cell function 178
Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System 177
Prognostic implications of diabetes phenotyping: new concepts for an old disease 175
Metabolic regulation of GLP-1 and PC1/3 in pancreatic α-cell line 175
Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy 173
Insulin resistance and endothelial dysfunction: A mutual relationship in cardiometabolic risk 171
Plasma N-Acetylaspartate Is Related to Age, Obesity, and Glucose Metabolism: Effects of Antidiabetic Treatment and Bariatric Surgery 169
Ectopic fat: The true culprit linking obesity and cardiovascular disease? 166
Effect of Dapagliflozin With and Without Acipimox on Insulin Sensitivity and Insulin Secretion in T2DM Males 165
Dapagliflozin enhances fat oxidation and ketone production in patients with type 2 diabetes 164
Bariatric surgery restores visual cortical plasticity in nondiabetic subjects with obesity 162
Effects of Treatment With Metformin and/or Sitagliptin on Beta-cell Function and Insulin Resistance in Prediabetic Women With Previous Gestational Diabetes 159
Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes 158
Fiber orientation measurements by diffusion tensor imaging improve hydrogen-1 magnetic resonance spectroscopy of intramyocellular lipids in human leg muscles 157
Association between a metabolic syndrome severity score and all- cause mortality in type 1 diabetes: a 10-year follow-up study 157
β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin 156
GLP-1 receptor agonists in type 1 diabetes: a proof-of-concept approach 154
Effect of fasting on short-term visual plasticity in adult humans 151
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes 151
Insulin resistance and risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 151
I nuovi farmaci per il diabete: gli inibitori del co-trasportatore sodio-glucosio di tipo 2 (SGLT-2i) 150
Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study 149
Membranous nephropathy and cerebellar degeneration with anti-GAD antibodies in type 2 diabetes mellitus 149
Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study 148
THE METABOLIC SYNDROME IS RELATED TO ALBUMINURIA IN TYPE 2 DIABETES 146
Determinants of the Increase in Fasting Plasma Ketone Concentration during SGLT2 Inhibition in NGT, IFG and T2DM Patients 144
Nesidioblastosis and Insulinoma: A Rare Coexistence and a Therapeutic Challenge 143
null 142
Efficacy and safety of once-weekly semaglutide monotherapy in a young subject with Prader-Willi syndrome, obesity, and type 2 diabetes: a case report 141
Terapia con metformina e rischio di acidosi lattica 141
Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes 140
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes 139
Cognitive Function and Brain Plasticity in Obese Patients—The Impact of Bariatric Surgery 136
Pioglitazone Inhibits Mitochondrial Pyruvate Metabolism and Glucose Production in Hepatocytes 135
Invited review. Series: Implications of the recent CVOTs in type 2 diabetes: Which patients for GLP-1RA or SGLT-2 inhibitor? 134
Breaking Therapeutic Inertia With Alirocumab in an 80-Year-Old Patient With Severe Hypercholesterolemia: A Case Report 134
Efficacy of Dulaglutide in a Patient With Type 2 Diabetes, High Cardiovascular Risk, and HIV: A Case Report 131
Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism 131
Discordance between central (Brain) and pancreatic action of exenatide in lean and obese subjects 131
Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus 130
Insulin resistance and risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study. diabetes care 2020;43:E139–e141 129
Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications 121
null 115
Pioglitazone corrects dysregulation of skeletal muscle mitochondrial proteins involved in ATP synthesis in type 2 diabetes 113
The potential role of the osteopontin–osteocalcin–osteoprotegerin triad in the pathogenesis of prediabetes in humans 109
null 108
Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion 106
Renal Denervation Attenuates Endogenous Glucose Production Increase with SGLT2 Inhibition in Patients with Renal Transplant Recipients and Impaired Fasting Glucose 106
Near-Infrared Spectroscopy: A Free-Living Neuroscience Tool to Better Understand Diabetes and Obesity 105
Empagliflozin and kinetics of renal glucose transport in healthy individuals and individuals with type 2 diabetes 105
Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients 104
Abnormalities of Insulin Secretion and ß-Cell Defects in Type 2 Diabetes 104
Circulating N-Acetylaspartate does not track brain NAA concentrations, cognitive function or features of small vessel disease in humans 100
Empagliflozin Treatment is Associated with Improved Beta Cell Function in T2DM 100
Inhibition of Renal Sodium-Glucose Co-Transport with Empagliflozin Lowers Fasting Plasma Glucose and Improves Beta Cell Function in Subjects With Impaired Fasting Glucose 99
null 96
Access to emergency room for hypoglycaemia in people with diabetes 94
Exenatide regulates pancreatic islet integrity and insulin sensitivity in the nonhuman primate baboon Papio hamadryas 91
Plasma N-acetylaspartate: development and validation of a quantitative assay based on HPLC-MS-MS and sample derivatization 88
null 84
Glucose Metabolism in High-Risk Subjects for Type 2 Diabetes Carrying the rs7903146 TCF7L2 Gene Variant 84
null 83
Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals 77
Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production 76
null 76
Treatment with Oral Drugs 69
What are the pharmacotherapy options for treating prediabetes? 67
null 63
null 60
Synthesis and biological evaluation of N–O heterobicyclic ring systems derived from 1,2-dihydropyridines as novel TRPA1 activators: implication in GLP-1 release and neuroprotection 56
null 48
The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus 47
Circulating N-Acetylaspartate Levels Associate with Measures of Peripheral and Tissue-Specific Insulin Sensitivity 43
Acute Supplementation of Beta-Hydroxybutyrate Increases Visual Cortical Excitability in Humans: A Combined Electro-EncephaloGraphy and Magnetic Resonance Spectroscopy Study 40
Current treatment for diabetes: a holistic approach 34
null 32
GLP ‐1 receptor agonist therapy for relapsed diabetes following 6q24‐related transient neonatal diabetes due to paternal uniparental disomy: A case report 30
Skipping breakfast changes visual processing: incretins contribution to short-term visual plasticity 29
Is It Worth Assessing the Prevalence of Sarcopenia in Pregnant Women? Should Any Impact on Pregnancy Outcomes Be Expected? 18
Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms 5
Metabolic determinants of torque teno virus load across the diabetes spectrum: insights from a cross-sectional analysis 3
Totale 13.679
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.994
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021149 0 0 0 0 0 0 0 0 0 0 55 94
2021/2022770 19 42 20 33 143 112 30 31 46 25 48 221
2022/20231.160 142 171 102 85 83 127 26 99 209 9 83 24
2023/2024907 75 92 89 70 124 128 64 25 23 54 61 102
2024/20253.089 66 122 86 167 278 309 317 169 295 432 289 559
2025/20263.933 226 437 701 375 361 274 533 268 218 495 45 0
Totale 13.679